Roti, kapda, makaan... and vaccine: Can it sway elections
With potential COVID-19 vaccines equalling cheap foodgrains’ power as a poll promise, can vaccine sub-nationalism be far behind
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
COVID-19 vaccines produce T-cell immunity that lasts and works against virus variants
Vaccines train the immune system to recognise and respond to a particular pathogen, without first having to be infected by it
Countries relying on Chinese COVID-19 vaccines see surge in cases: Report
Chile, Bahrain, Mongolia and the Sychelles relied on Chinese vaccines to inoculate their populations; all have registered a spike in COVID-19 …
COVID-19: How the state can make vaccinating transgenders easier
The central and the state governments must look after the community, with creative leadership and broad involvement of the community
New COVID-19 variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’
At least 3 documented SARS-CoV-2 variants of concern can reinfect recovered patients and vaccinated individuals
Resurgence of COVID-19 cases serious concern: Centre
‘Clinical trial mode’ condition of Covaxin manufactured by Bharat Biotech International taken off; Covaxin granted licence similar to …
Bhopal Covaxin trial participants allege side-effects, irregularities
Bhopal-based rights group writes to PM and Union health minister, demanding that ongoing Covaxin trial be halted there
Coronavirus vaccine: Why it’s important to know what’s in the placebo
Adding an actual vaccine to the placebo control helps the trial remain blinded and prevents bias arising from differing expectations
Moderna’s brazen patent grab on a COVID-19 jab
The US administration is finally putting its foot down on the appropriation of public research by drug firms
G20 Summit: 7 COVID-19 deaths every minute, rich countries urged to share soon-expiring vaccines
By the end of October, US, EU, Britain and Canada would have a stock of 240 million unused vaccines
Less than 10% of African countries likely to hit COVID-19 vaccination goal
The continent has so far fully vaccinated only 6% of its population; 70% of high-income countries have vaccinated more than 40% of their populations
Here’s the first Africa-wide survey of the economic impact of COVID-19 on cultural industries
There are factors explaining the harsh impact of the pandemic on cultural industries in Africa. These range from levels of informality and the …
Guillain-Barre: What is this neurological disorder — and how is it linked to COVID-19
Ninety-day national health emergency in Peru after 182 GBS cases reported since June 2023
Rwanda: 8 health workers arrested for stealing COVID-19 vaccines, test kits
The accused are employees of 4 health facilities in the country’s western and southern provinces
Omicron variant: How should India deal with a fresh surge in COVID-19 cases?
India reported 1,700 omicron cases as of January 3
COVID-19: Vaccine export to resume from next month, says Mandaviya
More than 300 million doses will be produced in October and more than a billion in the next quarter, according to Mansukh Mandaviya
COVID-19 vaccine weekly: Sharing doses tops the G7 agenda
Nepal has seen a surge in cases but has only vaccinated 2.5% of its population; Peru has the highest COVID-19 death rate per head of …
Who should or shouldn’t take the COVID-19 vaccine
The demand for vaccination has suddenly grown manifold after the devastating second wave of COVID-19. But there are many myths and misconceptions …
It will be months before there is consensus over COVID-19 vaccine patents: Experts
The United States has supported a temporary waiver on COVID-19 vaccine patents; but not all is hunky-dory, say experts
What South Africans should know, but don’t, about government’s COVID-19 vaccine procurement
Uncertainty remains around the exact role of South Africa’s nine provinces, each with its own legislature and executive council, on …
Intellectual property and COVID-19 medicines: Why a WTO waiver may not be enough
A waiver might not allow all developing countries to secure medicines and other anti-COVID technologies in a timely way
What Tanzania’s COVID-19 vaccine reluctance means for its citizens and the world
Only a few months into the pandemic, the president declared Tanzania COVID-free following three days of national prayers. The argument was that …
Omicron ‘re-infection’ raises questions about waning immunity against COVID-19. Here’s what we know
The metric being currently used to test waning immunity is an antibody test. Immunologists, however, have cautioned against an overreaction to …